ask="0.63"
ask_size="2500"
average_daily_volume="142485"
bid="0.57"
bid_size="200"
book_value="0.73"
change="-0.00"
change_from_200_day_moving_average="-0.73"
change_from_50_day_moving_average="-0.46"
change_from_52_week_high="-1.40"
change_From_52_week_low="0.04"
change_in_percent="-0.08%"
close="0.60"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.81"
ebitda="-30.60M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.86"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.62"
high_52_weeks="2.00"
last_trade_date="3/2/2017"
last_trade_price="0.60"
last_trade_size="866"
last_trade_time="4:00pm"
low="0.57"
low_52_weeks="0.56"
market_capitalization="23.19M"
moving_average_200_day="1.33"
moving_average_50_day="1.06"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="0.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-54.76%"
percent_change_from_50_day_moving_average="-43.43%"
percent_change_from_52_week_high="-70.00%"
percent_change_from_52_week_low="+7.14%"
previous_close="0.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.83"
price_per_sales="2.37"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.37"
stock_exchange="NMS"
symbol="AVIR"
volume="147721"
weeks_range_52="0.56 - 2.00"
